How does the soft-shell technique sustain dual-OVD utilisation per cataract surgery procedure?
The soft-shell phacoemulsification technique, popularised by Arshinoff, uses an initial injection of dispersive OVD to coat and protect the corneal endothelium followed by a cohesive OVD injection to maintain anterior chamber space and capsular bag distension during the procedure. This two-OVD approach consumes both a dispersive and a cohesive syringe per procedure, compared with single-OVD technique that uses one cohesive syringe alone, sustaining higher per-procedure OVD volume and revenue at surgical centres adopting the soft-shell approach for endothelial cell protection particularly in complex or challenging anterior segment anatomy cases.

What clinical advantages distinguish viscoadaptive OVDs from separate cohesive-dispersive combinations?
Viscoadaptive OVDs — characterised by pseudoplastic rheological behaviour that transitions from a cohesive viscosity profile under low-shear conditions maintaining anterior chamber space to a dispersive protective behaviour under high-shear phacoemulsification energy conditions — offer the convenience of a single-syringe product achieving the functional goals of the soft-shell dual-OVD technique. Viscoadaptive OVDs are positioned as premium single-syringe alternatives reducing procedure steps, surgical time, and potential for intraoperative errors from sequential OVD injections, sustaining premium pricing above standard cohesive or dispersive OVD products despite higher per-unit cost.

How do OVD requirements differ between cataract surgery and corneal transplantation?
Corneal transplantation procedures require OVD primarily for anterior chamber maintenance and donor endothelium protection during the graft positioning steps, with lower-volume, high-viscosity cohesive OVDs preferred for creating a stable anterior chamber space during graft unfolding. Descemet membrane endothelial keratoplasty procedures have specific requirements for OVDs that can be gently injected without disrupting the fragile Descemet membrane graft roll, sustaining demand for carefully characterised low-viscosity cohesive formulations at corneal transplant centres performing high-volume DMEK.

How does HPMC-based OVD sustain market position despite lower viscosity than hyaluronate products?
Hydroxypropyl methylcellulose OVDs — less expensive to manufacture than sodium hyaluronate-based products — maintain a presence in price-sensitive surgical markets including volume-based cataract programmes in lower-middle income countries where hyaluronate premium OVD cost represents a meaningful proportion of per-procedure surgical cost. HPMC products including Ocucoat and equivalent generics sustain market volume in Asia-Pacific and Latin American ophthalmic surgical markets where procurement price sensitivity limits premium hyaluronate OVD adoption despite hyaluronate’s superior rheological and endothelial protection characteristics.

How are glaucoma surgical OVD requirements sustaining specialised product demand?
Glaucoma filtration surgery requires OVD injection into the anterior chamber to maintain chamber depth during iridectomy and trabeculectomy fistula creation, with thorough OVD aspiration at procedure completion being particularly critical in trabeculectomy where residual OVD in the filtration bleb impairs aqueous outflow and causes transient IOP elevation. MIGS procedures implanting trabecular micro-bypass stents utilise OVD injection to maintain anterior chamber visualisation through the gonioscopy lens during ab-interno stent implantation, sustaining glaucoma surgical OVD demand proportional to MIGS and trabeculectomy procedure volume growth.

Which OVD segments are growing fastest?
Viscoadaptive single-syringe OVD adoption above separate soft-shell dual-OVD technique, premium sodium hyaluronate cohesive OVD endothelial protection positioning, MIGS procedure OVD utilisation from glaucoma surgical procedure volume growth, and DMEK corneal transplantation specialised low-viscosity OVD requirements are the four fastest-growing OVD segments.